q-PCR results showed that S1P treatment significantly reduced the level of LATS1/2, P21, and P53 induced by BX517 (Fig. 3K and S2E), which further proves the promoting effect of S1P on ovarian cancer cell senescence. The gene discussed is TP53; the disease is ovarian cancer.